4.6 Editorial Material

Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma Are We There Yet?

Journal

JAMA ONCOLOGY
Volume 6, Issue 8, Pages 1163-1164

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2020.0562

Keywords

-

Categories

Funding

  1. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development
  2. Center for Innovations in Quality, Effectiveness and Safety [CIN 13-413]
  3. Research Training Award for Cancer Prevention Post-Graduate Training Program in Integrative Epidemiology from the Cancer Prevention and Research Institute of Texas [RP160097]

Ask authors/readers for more resources

This Viewpoint advocates for increased use of neoadjuvant therapy in the treatment of localized pancreatic adenocarcinoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available